SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Companyâs key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
äŒæ¥ã³ãŒãSOPH
äŒç€ŸåSOPHiA GENETICS SA
äžå Žæ¥Jul 23, 2021
æé«çµå¶è²¬ä»»è
ãCEOãCamblong (Jurgi)
åŸæ¥å¡æ°423
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jul 23
æ¬ç€Ÿæåšå°La Piece 12
éœåžROLLE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœSwitzerland
éµäŸ¿çªå·CH-1180
é»è©±çªå·41216941060
ãŠã§ããµã€ãhttps://www.sophiagenetics.com/
äŒæ¥ã³ãŒãSOPH
äžå Žæ¥Jul 23, 2021
æé«çµå¶è²¬ä»»è
ãCEOãCamblong (Jurgi)